Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma

4 Feb 2021

Abstract excerpt

Objectives: Glioma is the most common and aggressive type of primary central nervous system (CNS) tumor in adults and is associated with substantial mortality rates. The aim of our study was to evaluate the prognostic significance and function of the complement factor I (CFI) in glioma. Materials and Methods: The expression levels of CFI in glioma tissues and the survival of the CFIhigh and CFIlow patient groups...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Glioma Diagnosis and Treatment
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33614625
DOI: 10.3389/fcell.2020.615970

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in GliomaPMID 33614625Read ↗

The Predictive and Therapeutic Role of Complement in GliomasSemantic proximity Read ↗

Bioinformatics Analysis of C3 in Brain Low Grade Gliomas as Potential Therapeutic Target and Promoting Immune Cell InfiltrationSemantic proximity Read ↗

Immunological and clinicopathological characteristics of C1RL in 2120 glioma patientsSemantic proximity Read ↗

Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade gliomaSemantic proximity Read ↗

A Comprehensive Bioinformatic Analysis of RFC1/2/3/4/5 As Significant Clinical Indicators in The Diagnosis and Prognosis of Low-Grade GliomaSemantic proximity Read ↗

APOBEC3C Served as a Novel Immune-Related Prognosis Biomarker in Glioma: A Pan-Cancer AnalysisSemantic proximity Read ↗

Exploration of the biological mechanisms of CENPA as an oncogene in glioma: Screening based on cancer functional statusSemantic proximity Read ↗

CMIP Promotes Proliferation and Metastasis in Human GliomaSemantic proximity Read ↗

CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas.Semantic proximity Read ↗

CIA-II is associated with lower-grade glioma survival and cell proliferation.Semantic proximity Read ↗

Hypoxia-induced Complement Component 3 Promotes Aggressive Tumor Growth in the Glioblastoma MicroenvironmentSemantic proximity Read ↗

CPLX2 is a novel tumor suppressor and improves the prognosis in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.